Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment
Our study validates the effective prognostic capacity of the GAR-based nomogram for HCC patients undergoing TACE or TACE in combination with systemic therapy.
Authors
- Zhen-Ying Wu (ORCID: https://orcid.org/0000-0002-4789-4545)
- Meng‐Tzu Weng (ORCID: https://orcid.org/0000-0002-4143-6607)
- Ke Su (ORCID: https://orcid.org/0000-0002-7948-6335)
- Yunwei Han (ORCID: https://orcid.org/0000-0001-8330-0444)
- Han Li (ORCID: https://orcid.org/0000-0002-7380-6174)
- Jiali Chen (ORCID: https://orcid.org/0000-0001-7929-5136)
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-11-08
- DOI
- https://doi.org/10.4251/wjgo.v16.i12.4650
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- Southwest Medical University
- Affiliated Hospital of Southwest Medical University